Article
Constitutive Activation of the Mitogen-Activated Protein Kinase Signaling Pathway in Acral Melanomas
1 Aug 2005
Abstract excerpt
One of the most attractive clinical targets for melanoma is the mitogen-activated protein kinase (MAPK) signaling pathway. In this study, we examined MAPK signaling activation in a total of 28 acral melanoma samples, consisting of 13 primary tumors and 15 metastases. In line with the previous reports, NRAS/BRAF mutations were rare; only one metastatic tumor had an NRAS E61R mutation, and one primary tumor and two...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
